Loading…
New indole amide derivatives as potent CRTH2 receptor antagonists
A new series of indole amide acting as hCRTH2 receptor ligands had been explored and are described herein. Several amide derivatives displaying low nanomolar activity in hCRTH2 binding and whole blood assays were identified. They were found to behave as a full antagonists, exhibiting good selectivit...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2011-06, Vol.21 (11), p.3471-3474 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3 |
container_end_page | 3474 |
container_issue | 11 |
container_start_page | 3471 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 21 |
creator | Zaghdane, Helmi Boyd, Michael Colucci, John Simard, Daniel Berthelette, Carl Leblanc, Yves Wang, Zhaoyin Houle, Robert Lévesque, Jean François Molinaro, Carmela Hamel, Martine Stocco, Rino Sawyer, Nicole Sillaots, Susan Gervais, François Gallant, Michel |
description | A new series of indole amide acting as hCRTH2 receptor ligands had been explored and are described herein. Several amide derivatives displaying low nanomolar activity in hCRTH2 binding and whole blood assays were identified. They were found to behave as a full antagonists, exhibiting good selectivity over related prostaglandin receptors. Also, prototypical compounds in this novel series which displayed acceptable CYP profiles and were orally bioavailable in rats were identified. |
doi_str_mv | 10.1016/j.bmcl.2011.03.085 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_872133822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X11004045</els_id><sourcerecordid>872133822</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3</originalsourceid><addsrcrecordid>eNqFkUuLFDEQgIMo7rj6BzxoX8RTt3knDV6WQV1hUdBd8Baq09VLhn6MSWbEf2-aGfWmp4Kqrx58RchzRhtGmX6za7rJjw2njDVUNNSqB2TDpJa1kFQ9JBvaalrbVn67IE9S2lHKJJXyMbngTDFFldiQq0_4owpzv4xYwRR6rHqM4Qg5HDFVkKr9knHO1fbL7TWvInrc5yVWMGe4X-aQcnpKHg0wJnx2jpfk7v272-11ffP5w8ft1U3tpWS5HtArwcRgjPEwABjR6q6z0IOhkre6pG0HzIjOaKb5WpXaCC6kYqaVvbgkr09z93H5fsCU3RSSx3GEGZdDctZwJoTl_P-ktpQbLk0h-Yn0cUkp4uD2MUwQfzpG3erY7dzq2K2OHRWuOC5NL87jD92E_Z-W31IL8OoMQPIwDhFmH9JfTnLBtFrvfHniBlgc3MfC3H0tm1R5lJDWskK8PRFYxB4DRpd8wNljH8orsuuX8K9LfwFwUKER</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>868027247</pqid></control><display><type>article</type><title>New indole amide derivatives as potent CRTH2 receptor antagonists</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Zaghdane, Helmi ; Boyd, Michael ; Colucci, John ; Simard, Daniel ; Berthelette, Carl ; Leblanc, Yves ; Wang, Zhaoyin ; Houle, Robert ; Lévesque, Jean François ; Molinaro, Carmela ; Hamel, Martine ; Stocco, Rino ; Sawyer, Nicole ; Sillaots, Susan ; Gervais, François ; Gallant, Michel</creator><creatorcontrib>Zaghdane, Helmi ; Boyd, Michael ; Colucci, John ; Simard, Daniel ; Berthelette, Carl ; Leblanc, Yves ; Wang, Zhaoyin ; Houle, Robert ; Lévesque, Jean François ; Molinaro, Carmela ; Hamel, Martine ; Stocco, Rino ; Sawyer, Nicole ; Sillaots, Susan ; Gervais, François ; Gallant, Michel</creatorcontrib><description>A new series of indole amide acting as hCRTH2 receptor ligands had been explored and are described herein. Several amide derivatives displaying low nanomolar activity in hCRTH2 binding and whole blood assays were identified. They were found to behave as a full antagonists, exhibiting good selectivity over related prostaglandin receptors. Also, prototypical compounds in this novel series which displayed acceptable CYP profiles and were orally bioavailable in rats were identified.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2011.03.085</identifier><identifier>PMID: 21515053</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Amides - chemical synthesis ; Amides - chemistry ; Amides - pharmacology ; Animals ; antagonists ; Asthma ; Biological and medical sciences ; blood ; CRTH2 receptor antagonists ; DP2 receptor antagonist ; Histamine and antagonists. Allergy ; Indoles - chemical synthesis ; Indoles - chemistry ; Indoles - pharmacology ; Inhibitory Concentration 50 ; Ligands ; Medical sciences ; MK-7246 ; Molecular Structure ; Pharmacology. Drug treatments ; Prostaglandin receptors ; prostaglandins ; Protein Binding - drug effects ; Rats ; receptors ; Receptors, Dopamine D2 - agonists ; Respiratory system</subject><ispartof>Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3471-3474</ispartof><rights>2011 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3</citedby><cites>FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24231652$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21515053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zaghdane, Helmi</creatorcontrib><creatorcontrib>Boyd, Michael</creatorcontrib><creatorcontrib>Colucci, John</creatorcontrib><creatorcontrib>Simard, Daniel</creatorcontrib><creatorcontrib>Berthelette, Carl</creatorcontrib><creatorcontrib>Leblanc, Yves</creatorcontrib><creatorcontrib>Wang, Zhaoyin</creatorcontrib><creatorcontrib>Houle, Robert</creatorcontrib><creatorcontrib>Lévesque, Jean François</creatorcontrib><creatorcontrib>Molinaro, Carmela</creatorcontrib><creatorcontrib>Hamel, Martine</creatorcontrib><creatorcontrib>Stocco, Rino</creatorcontrib><creatorcontrib>Sawyer, Nicole</creatorcontrib><creatorcontrib>Sillaots, Susan</creatorcontrib><creatorcontrib>Gervais, François</creatorcontrib><creatorcontrib>Gallant, Michel</creatorcontrib><title>New indole amide derivatives as potent CRTH2 receptor antagonists</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A new series of indole amide acting as hCRTH2 receptor ligands had been explored and are described herein. Several amide derivatives displaying low nanomolar activity in hCRTH2 binding and whole blood assays were identified. They were found to behave as a full antagonists, exhibiting good selectivity over related prostaglandin receptors. Also, prototypical compounds in this novel series which displayed acceptable CYP profiles and were orally bioavailable in rats were identified.</description><subject>Amides - chemical synthesis</subject><subject>Amides - chemistry</subject><subject>Amides - pharmacology</subject><subject>Animals</subject><subject>antagonists</subject><subject>Asthma</subject><subject>Biological and medical sciences</subject><subject>blood</subject><subject>CRTH2 receptor antagonists</subject><subject>DP2 receptor antagonist</subject><subject>Histamine and antagonists. Allergy</subject><subject>Indoles - chemical synthesis</subject><subject>Indoles - chemistry</subject><subject>Indoles - pharmacology</subject><subject>Inhibitory Concentration 50</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>MK-7246</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Prostaglandin receptors</subject><subject>prostaglandins</subject><subject>Protein Binding - drug effects</subject><subject>Rats</subject><subject>receptors</subject><subject>Receptors, Dopamine D2 - agonists</subject><subject>Respiratory system</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkUuLFDEQgIMo7rj6BzxoX8RTt3knDV6WQV1hUdBd8Baq09VLhn6MSWbEf2-aGfWmp4Kqrx58RchzRhtGmX6za7rJjw2njDVUNNSqB2TDpJa1kFQ9JBvaalrbVn67IE9S2lHKJJXyMbngTDFFldiQq0_4owpzv4xYwRR6rHqM4Qg5HDFVkKr9knHO1fbL7TWvInrc5yVWMGe4X-aQcnpKHg0wJnx2jpfk7v272-11ffP5w8ft1U3tpWS5HtArwcRgjPEwABjR6q6z0IOhkre6pG0HzIjOaKb5WpXaCC6kYqaVvbgkr09z93H5fsCU3RSSx3GEGZdDctZwJoTl_P-ktpQbLk0h-Yn0cUkp4uD2MUwQfzpG3erY7dzq2K2OHRWuOC5NL87jD92E_Z-W31IL8OoMQPIwDhFmH9JfTnLBtFrvfHniBlgc3MfC3H0tm1R5lJDWskK8PRFYxB4DRpd8wNljH8orsuuX8K9LfwFwUKER</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Zaghdane, Helmi</creator><creator>Boyd, Michael</creator><creator>Colucci, John</creator><creator>Simard, Daniel</creator><creator>Berthelette, Carl</creator><creator>Leblanc, Yves</creator><creator>Wang, Zhaoyin</creator><creator>Houle, Robert</creator><creator>Lévesque, Jean François</creator><creator>Molinaro, Carmela</creator><creator>Hamel, Martine</creator><creator>Stocco, Rino</creator><creator>Sawyer, Nicole</creator><creator>Sillaots, Susan</creator><creator>Gervais, François</creator><creator>Gallant, Michel</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20110601</creationdate><title>New indole amide derivatives as potent CRTH2 receptor antagonists</title><author>Zaghdane, Helmi ; Boyd, Michael ; Colucci, John ; Simard, Daniel ; Berthelette, Carl ; Leblanc, Yves ; Wang, Zhaoyin ; Houle, Robert ; Lévesque, Jean François ; Molinaro, Carmela ; Hamel, Martine ; Stocco, Rino ; Sawyer, Nicole ; Sillaots, Susan ; Gervais, François ; Gallant, Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Amides - chemical synthesis</topic><topic>Amides - chemistry</topic><topic>Amides - pharmacology</topic><topic>Animals</topic><topic>antagonists</topic><topic>Asthma</topic><topic>Biological and medical sciences</topic><topic>blood</topic><topic>CRTH2 receptor antagonists</topic><topic>DP2 receptor antagonist</topic><topic>Histamine and antagonists. Allergy</topic><topic>Indoles - chemical synthesis</topic><topic>Indoles - chemistry</topic><topic>Indoles - pharmacology</topic><topic>Inhibitory Concentration 50</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>MK-7246</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Prostaglandin receptors</topic><topic>prostaglandins</topic><topic>Protein Binding - drug effects</topic><topic>Rats</topic><topic>receptors</topic><topic>Receptors, Dopamine D2 - agonists</topic><topic>Respiratory system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zaghdane, Helmi</creatorcontrib><creatorcontrib>Boyd, Michael</creatorcontrib><creatorcontrib>Colucci, John</creatorcontrib><creatorcontrib>Simard, Daniel</creatorcontrib><creatorcontrib>Berthelette, Carl</creatorcontrib><creatorcontrib>Leblanc, Yves</creatorcontrib><creatorcontrib>Wang, Zhaoyin</creatorcontrib><creatorcontrib>Houle, Robert</creatorcontrib><creatorcontrib>Lévesque, Jean François</creatorcontrib><creatorcontrib>Molinaro, Carmela</creatorcontrib><creatorcontrib>Hamel, Martine</creatorcontrib><creatorcontrib>Stocco, Rino</creatorcontrib><creatorcontrib>Sawyer, Nicole</creatorcontrib><creatorcontrib>Sillaots, Susan</creatorcontrib><creatorcontrib>Gervais, François</creatorcontrib><creatorcontrib>Gallant, Michel</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zaghdane, Helmi</au><au>Boyd, Michael</au><au>Colucci, John</au><au>Simard, Daniel</au><au>Berthelette, Carl</au><au>Leblanc, Yves</au><au>Wang, Zhaoyin</au><au>Houle, Robert</au><au>Lévesque, Jean François</au><au>Molinaro, Carmela</au><au>Hamel, Martine</au><au>Stocco, Rino</au><au>Sawyer, Nicole</au><au>Sillaots, Susan</au><au>Gervais, François</au><au>Gallant, Michel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New indole amide derivatives as potent CRTH2 receptor antagonists</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>21</volume><issue>11</issue><spage>3471</spage><epage>3474</epage><pages>3471-3474</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A new series of indole amide acting as hCRTH2 receptor ligands had been explored and are described herein. Several amide derivatives displaying low nanomolar activity in hCRTH2 binding and whole blood assays were identified. They were found to behave as a full antagonists, exhibiting good selectivity over related prostaglandin receptors. Also, prototypical compounds in this novel series which displayed acceptable CYP profiles and were orally bioavailable in rats were identified.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>21515053</pmid><doi>10.1016/j.bmcl.2011.03.085</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2011-06, Vol.21 (11), p.3471-3474 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_872133822 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Amides - chemical synthesis Amides - chemistry Amides - pharmacology Animals antagonists Asthma Biological and medical sciences blood CRTH2 receptor antagonists DP2 receptor antagonist Histamine and antagonists. Allergy Indoles - chemical synthesis Indoles - chemistry Indoles - pharmacology Inhibitory Concentration 50 Ligands Medical sciences MK-7246 Molecular Structure Pharmacology. Drug treatments Prostaglandin receptors prostaglandins Protein Binding - drug effects Rats receptors Receptors, Dopamine D2 - agonists Respiratory system |
title | New indole amide derivatives as potent CRTH2 receptor antagonists |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A39%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20indole%20amide%20derivatives%20as%20potent%20CRTH2%20receptor%20antagonists&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Zaghdane,%20Helmi&rft.date=2011-06-01&rft.volume=21&rft.issue=11&rft.spage=3471&rft.epage=3474&rft.pages=3471-3474&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2011.03.085&rft_dat=%3Cproquest_cross%3E872133822%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c441t-fec5313f777cafaa7396bb8ada70429677c8ba173b76162396b467323451794d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=868027247&rft_id=info:pmid/21515053&rfr_iscdi=true |